The combination of a toxic convertible note with anti-dilution ratchets, a massive authorized share increase, and an activist 13D filing creates a high-probability downside scenario. Watch for the December 4, 2026 anti-dilution trigger date — if the note isn't repaid by then, warrant exercise prices will ratchet down, accelerating dilution. The special meeting vote on October 30 is the key catalyst; if all proposals pass, expect immediate selling pressure as the market prices in the dilutive overhang.
Price Chart
Executive Summary
Banzai International is holding a special meeting on October 30, 2026, to seek shareholder approval for a massive authorized share increase from 350M to 850M shares, authorization of a potential $14M public offering with deeply discounted pricing (floor prices as low as 30-50% of market), and ratification of a toxic convertible note and warrant deal with Evergreen Capital Management that already closed on September 4, 2026. The filing reveals severe financial distress — the company has only ~4.5M shares outstanding but needs to authorize up to 750M Class A shares to accommodate a $2.14M convertible note (30% OID, 10% interest) and warrants that could flood the market with up to 2.6M shares at $2.75, with anti-dilution ratchets that could push conversion prices even lower. An activist investor (Alco Investment Co.) filed a 13D/A on August 18, 2026, signaling potential proxy fight or governance pressure ahead of this meeting.
Key Facts
- Authorized share increase from 350M to 850M shares (up to 750M Class A, 25M Class B, 75M preferred) — a 143% increase
- Only 4,359,146 Class A and 149,821 Class B shares outstanding as of September 28, 2026 record date
- Potential public offering of up to $14M with floor prices as low as 50% (conversion) and 30% (exercise) of the minimum price
- Evergreen Capital Management convertible note: $2.14M initial principal (expandable to $3.57M), 30% original issue discount, 10% interest (18% default), matures June 4, 2027
- Note conversion price: $2.75/share; warrants exercisable at $2.75/share for up to 1,298,701 shares total
- Exchange cap of 784,612 shares currently limits issuance; Proposal 3 seeks to remove this cap entirely
- Anti-dilution trigger: if note not repaid within 90 days of closing (by ~December 4, 2026), warrant exercise price can ratchet down to the lower of any dilutive issuance price or 5-day VWAP
- Voluntary adjustment provision allows board to reduce conversion/exercise prices at any time with holder consent
- Activist Alco Investment Co. filed SC 13D/A on August 18, 2026 — potential proxy fight context
- Board unanimously recommends FOR all proposals; no dissenting director identified
Financial Impact
Massive dilution: current ~4.5M shares outstanding could expand to 750M authorized Class A shares. The Evergreen deal alone could add ~2.6M shares at $2.75, but with anti-dilution ratchets and voluntary price adjustments, the actual dilutive impact could be far larger. The $14M potential offering at deeply discounted prices (30-50% of market) would further crush existing shareholders.
Risk Factors
- Extreme dilution: authorized shares increasing 143% with no shareholder preemptive rights
- Toxic financing structure: 30% OID convertible note with anti-dilution ratchets and voluntary price adjustments creates a death spiral dynamic
- Activist 13D filing (Alco Investment Co.) could lead to proxy fight or board changes, adding uncertainty
- Potential delisting risk if Nasdaq listing standards violated by massive share issuance below minimum price
- Company may be unable to repay the Evergreen note by December 4, 2026, triggering anti-dilution adjustments
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001437749-26-032835 |
| Document: 0001437749-26-032835-index-headers.html | 0001437749-26-032835 |
| Document: 0001437749-26-032835-index.html | 0001437749-26-032835 |
| Document: 0001437749-26-032835.txt | 0001437749-26-032835 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.4251 $0.4101 | ▼ −3.53% | ▼ −4.24% | — |
Oct 21, 2026 5d ago | 8-K | $0.5100 $0.4700 | ▼ −7.84% | ▼ −6.66% | — |
Oct 20, 2026 6d ago | DEF 14A | $0.5360 $0.5100 | ▲ +4.85% | ▲ +5.38% | — |
Oct 1, 2026 25d ago | 8-K | $0.5760 $0.5220 | ▼ −9.38% | ▼ −10.11% | — |
Aug 14, 2026 10w ago | Press Release | $1.45 $1.36 | ▲ +6.21% | ▲ +5.53% | — |
Aug 13, 2026 10w ago | 8-K | $1.70 $1.70 | · 0.00% | ▼ −0.20% | — |
Aug 12, 2026 10w ago | Press Release | $1.70 $1.70 | · 0.00% | ▲ +0.20% | — |
Jun 12, 2026 19w ago | Institutional Cluster | — | awaiting T+1 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers